Latest twenty posts reanalysis reasons [bioanalytics] In order to log in, cookies have to be allowed Qualityassurance 05:39 ago dosing of oral sprinkle granules [design issues]
Loky do 1 day 00:51 ago deferasirox fast study [regulatives / guidelines] Next you should check if the first concentration measured is within the range of cmax of the study. Mokhtar saleh 1 day 00:53 ago filgotinib ddi
Mittyri 8 days 07:43 ago ich m12 drug. A platform for discussions on bioequivalence and bioavailability studies, offering insights and expertise in clinical trials and regulatory processes. The beba forum isn’t sms or a real time chat application like whatsapp, telegram, signal, threema In those type of services a person often needs to quickly get their response across otherwise it gets lost in the sea of other responses.
Bioequivalence and bioavailability forum • deviating from assumptionsthread view Bioequivalence and bioavailability forum • news from ema Dears in a bioequivalence study of deferasirox oral sprinkle granules, the fda draft guidance recommends conducting both fasted and fed studies However, the fda label states that the dose should be administered by sprinkling the granules onto a soft food such as yogurt or applesauce
Dear smitha to my opinion there is no justification to exclude the subject with first point cmax from pk and statistical analysis
